Gentaur Nivolumab – Anti-PD-1 Antibody

https://www.pathco.org/web/image/product.template/137761/image_1920?unique=6dd64d0
(0 review)
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.


Internal Reference: GMA-PD-1
Display Name: [GMA-PD-1] Gentaur Nivolumab – Anti-PD-1 Antibody
Image 512: